In a retrospective cohort study including 7,044 patients with T2D, obesity (BMI 27 kg/m 2 ) and HFpEF, combination therapy with an SGLT2i and GLP-1 RA showed a lower risk of HF exacerbation, all-cause emergency department visits and new-onset kidney injury compared with patients only receiving SGLT2i
Serving examples Everyday support (7501500 mg): 1 bottle (12.525 ml)
Peptides that support immune function, cellular energy, and longevity for healthy aging
Potential Side Effects : Some mild bruising, swelling, or tenderness might occur, but these are temporary and should fade within a few days
Younger generations are already moving towards convenience-first healthcare Adults under 45 consistently showed the strongest interest in oral GLP-1s throughout our research